"Patients should be more demanding that they are getting the lowest dose possible, " says Gene Saragnese, who runs imaging systems for Philips Healthcare.
Most prominently, teenager Jesse Gelsinger died from multiple organ failure a few days after receiving a massive dose of virus-based gene therapy in a trial at the University of Pennsylvania.